Sell Ranbaxy, says Sanjeev Agarwal, CEO of Dynamix Research & Capital Management.
Agarwal told CNBC-TV18, "After showing some strength in past few days Ranbaxy looks tired now and we can sell it at CMP of Rs 515 with a stop loss above Rs 525. We can see the target of Rs 500 and below it may go upto Rs 485.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
